"Palivizumab Therapy for RSV-bronchiolitis"
Clinical trial NCT02442427 · COMPLETED
Trial details
- NCT number
- NCT02442427
- Sponsor
- Hamad Medical Corporation
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-09-01
- Primary completion
- 2018-02-01
- Enrollment
- 420
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.